Discover how to develop an effective publications strategy for rare diseases with a recent article from the MAP newsletter.
Are you familiar with the FAIR data principles? Find out how to boost your data’s usefulness by making your data FAIR: Findable, Accessible, Interoperable, and Reusable.
A recent article in Medical Writing provides insights into the importance of patient reported outcomes in publication planning and guidance for best practice.
Cochrane members have become divided over growing centralisation of the organisation. An article in The BMJ explores the question, “Has Cochrane lost its way?”.
A free 90-minute webinar from ISMPP, open to all.
Increasing quality and transparency of preclinical data: an opportunity for publication professionals?
An article in the MAP newsletter examines how publication professionals could help to increase preclinical publishing standards.
While mirror journals have been proposed as an alternative to hybrid journals for open access publishing under Plans S, recent guidance indicates they may not be compliant.
A recent article from Science explores how meta-analyses may be less authoritative than they seem.
Researchers at Nature uncover the world’s most hyperprolific authors and question our understanding of scientific authorship.
In a recent opinion piece the traditional scientific publishing model is reviewed alongside recent efforts to change it.
Tips for evidence-based publication planning, including gap and SWOT analysis, are provided in a recent issue of the MAP newsletter.
The Wellcome Trust announces a new open access policy, which includes five key updates.
Journals and funders pledge to publish peer review reports in a move to increase transparency of the publication process.
Tim Ellison reviews the growing importance of preprints in medical publishing.
Is the apparent efficacy of treatments being altered by bias? A recent study takes a closer look at the cumulative effects of reporting and citation biases.
Is your institute breaking European clinical trial reporting rules? Find out using the new EU trials tracker, part of the AllTrials initiative.